Cargando…
Reliability of dynamic susceptibility contrast perfusion metrics in pre- and post-treatment glioma
BACKGROUND: In neuro-oncology, dynamic susceptibility contrast magnetic resonance (DSC-MR) perfusion imaging emerged as a tool to aid in the diagnostic work-up and to surveil effectiveness of treatment. However, it is believed that a significant variability exists with regard to the measured in DSC-...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205029/ https://www.ncbi.nlm.nih.gov/pubmed/35715866 http://dx.doi.org/10.1186/s40644-022-00466-2 |
_version_ | 1784729044156153856 |
---|---|
author | Kouwenberg, Valentina van Santwijk, Lusien Meijer, Frederick J. A. Henssen, Dylan |
author_facet | Kouwenberg, Valentina van Santwijk, Lusien Meijer, Frederick J. A. Henssen, Dylan |
author_sort | Kouwenberg, Valentina |
collection | PubMed |
description | BACKGROUND: In neuro-oncology, dynamic susceptibility contrast magnetic resonance (DSC-MR) perfusion imaging emerged as a tool to aid in the diagnostic work-up and to surveil effectiveness of treatment. However, it is believed that a significant variability exists with regard to the measured in DSC-MR perfusion parameters. The aim of this study was to assess the observer variability in measured DSC-MR perfusion parameters in patients before and after treatment. In addition, we investigated whether region-of-interest (ROI) shape impacted the observer variability. MATERIALS AND METHODS: Twenty non-treated patients and a matched group of twenty patients post-treatment (neurosurgical resection and post-chemoradiotherapy) were included. Six ROIs were independently placed by three readers: circular ROIs and polygonal ROIs covering 1) the tumor hotspot; 2) the peritumoral region (T2/FLAIR-hyperintense region) and 3) the whole tumor region. A two-way random Intra-class coefficient (ICC) model was used to assess variability in measured DSC-MRI perfusion parameters. The perfusion metrics as assessed by the circular and the polygonal ROI were compared by use of the dependent T-test. RESULTS: In the non-treated group, circular ROIs showed good–excellent overlap (ICC-values ranging from 0.741–0.963) with the exception of those representing the tumor hotspot. Polygonal ROIs showed lower ICC-values, ranging from 0.113 till 0.856. ROI-placement in the posttreatment group showed to be highly variable with a significant deterioration of ICC-values. Furthermore, perfusion metric assessment in similar tumor regions was not impacted by ROI shape. DISCUSSION: This study shows that posttreatment quantitative interpretation of DSC-MR perfusion imaging is highly variable and should be carried out with precaution. Pretreatment assessment of DSC-MR images, however, could be carried out be a single reader in order to provide valid data for further analyses. |
format | Online Article Text |
id | pubmed-9205029 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-92050292022-06-18 Reliability of dynamic susceptibility contrast perfusion metrics in pre- and post-treatment glioma Kouwenberg, Valentina van Santwijk, Lusien Meijer, Frederick J. A. Henssen, Dylan Cancer Imaging Research Article BACKGROUND: In neuro-oncology, dynamic susceptibility contrast magnetic resonance (DSC-MR) perfusion imaging emerged as a tool to aid in the diagnostic work-up and to surveil effectiveness of treatment. However, it is believed that a significant variability exists with regard to the measured in DSC-MR perfusion parameters. The aim of this study was to assess the observer variability in measured DSC-MR perfusion parameters in patients before and after treatment. In addition, we investigated whether region-of-interest (ROI) shape impacted the observer variability. MATERIALS AND METHODS: Twenty non-treated patients and a matched group of twenty patients post-treatment (neurosurgical resection and post-chemoradiotherapy) were included. Six ROIs were independently placed by three readers: circular ROIs and polygonal ROIs covering 1) the tumor hotspot; 2) the peritumoral region (T2/FLAIR-hyperintense region) and 3) the whole tumor region. A two-way random Intra-class coefficient (ICC) model was used to assess variability in measured DSC-MRI perfusion parameters. The perfusion metrics as assessed by the circular and the polygonal ROI were compared by use of the dependent T-test. RESULTS: In the non-treated group, circular ROIs showed good–excellent overlap (ICC-values ranging from 0.741–0.963) with the exception of those representing the tumor hotspot. Polygonal ROIs showed lower ICC-values, ranging from 0.113 till 0.856. ROI-placement in the posttreatment group showed to be highly variable with a significant deterioration of ICC-values. Furthermore, perfusion metric assessment in similar tumor regions was not impacted by ROI shape. DISCUSSION: This study shows that posttreatment quantitative interpretation of DSC-MR perfusion imaging is highly variable and should be carried out with precaution. Pretreatment assessment of DSC-MR images, however, could be carried out be a single reader in order to provide valid data for further analyses. BioMed Central 2022-06-17 /pmc/articles/PMC9205029/ /pubmed/35715866 http://dx.doi.org/10.1186/s40644-022-00466-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Kouwenberg, Valentina van Santwijk, Lusien Meijer, Frederick J. A. Henssen, Dylan Reliability of dynamic susceptibility contrast perfusion metrics in pre- and post-treatment glioma |
title | Reliability of dynamic susceptibility contrast perfusion metrics in pre- and post-treatment glioma |
title_full | Reliability of dynamic susceptibility contrast perfusion metrics in pre- and post-treatment glioma |
title_fullStr | Reliability of dynamic susceptibility contrast perfusion metrics in pre- and post-treatment glioma |
title_full_unstemmed | Reliability of dynamic susceptibility contrast perfusion metrics in pre- and post-treatment glioma |
title_short | Reliability of dynamic susceptibility contrast perfusion metrics in pre- and post-treatment glioma |
title_sort | reliability of dynamic susceptibility contrast perfusion metrics in pre- and post-treatment glioma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205029/ https://www.ncbi.nlm.nih.gov/pubmed/35715866 http://dx.doi.org/10.1186/s40644-022-00466-2 |
work_keys_str_mv | AT kouwenbergvalentina reliabilityofdynamicsusceptibilitycontrastperfusionmetricsinpreandposttreatmentglioma AT vansantwijklusien reliabilityofdynamicsusceptibilitycontrastperfusionmetricsinpreandposttreatmentglioma AT meijerfrederickja reliabilityofdynamicsusceptibilitycontrastperfusionmetricsinpreandposttreatmentglioma AT henssendylan reliabilityofdynamicsusceptibilitycontrastperfusionmetricsinpreandposttreatmentglioma |